Baylor Scott & White Health

Temple, Texas 76508

6 studies enrolling now · 23 studies all time

What they study most

Acute Respiratory Distress Syndrome, Acute Respiratory Failure, Adult Solid Tumor, Advanced/Metastatic Non-Small Cell Lung Cancer, Aging, B-Cell Non-Hodgkins Lymphoma, Brain Neoplasms, Adult, Malignant, Brain Tumor, Breast Cancer, Breast Reconstruction, Bronchitis, COVID-19 Pneumonia

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer — Recruiting now
• A Study to Investigate Ubamatamab With and Without REGN7075 in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) — Recruiting now
• A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma — Recruiting now
• A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity — Recruiting now
• Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS) — Recruiting now
• Annual Wellness Visits vs GRACE-augmented Annual Wellness Visits For Older Adults With High Needs - Phase 2 — Recruiting now
• A Study of Baricitinib in Participants With Rheumatoid Arthritis — Completed
• A Study of the Safety and Effectiveness of the Mentor Larger Size MemoryGel Ultra High Profile Breast Implants in Subjects Who Are Undergoing Primary Breast Reconstruction or Revision Reconstruction — Running, not enrolling
• A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated Glioblastoma — Running, not enrolling
• Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) — Running, not enrolling
• Study of the Efficacy and Safety of AMAG-423 (Digoxin Immune Fab) in Antepartum Subjects With Severe Preeclampsia — Stopped early
• A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Urothelial Carcinoma - (FIGHT-201) — Completed
• A Study of IMR-687 in Adult Participants With Sickle Cell Anemia (Homozygous HbSS or Sickle-β0 Thalassemia) — Completed
• Pragmatic Trial Examining Oxygenation Prior to Intubation — Completed
• DirEct Versus VIdeo LaryngosCopE Trial — Completed
• A Study of the Intra-Patient Escalation Dosing Regimen With IMCgp100 in Patients With Advanced Uveal Melanoma — Completed
• A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM) — Completed
• Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101) — Stopped early
• Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100) — Completed
• A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia — Completed
• Peer Support for Post Intensive Care Syndrome Self-Management — Status unconfirmed
• Study of Urate Elevation in Parkinson's Disease, Phase 3 — Completed
• A Multi-Site Clinical Evaluation of the ARIES Flu Assay in Symptomatic Patients — Status unconfirmed